WALTHAM, Mass., Oct. 02, 2023 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS)...
Category - New Drugs
FDA Approves Technegas (Technetium Tc 99-m Labeled Carbon)...
October 2, 2023 — Cyclopharm Limited (ASX: CYC) announces the company has received United...
FDA Approves Rivfloza (nedosiran) for the Treatment of Primary Hyperoxaluria Type 1 (PH1)
FDA Approves Tofidence (tocilizumab-bavi), a Biosimilar to Actemra
FDA Approves Exxua (gepirone) for the Treatment of Major Depressive Disorder in Adults
FDA Approves Pombiliti (cipaglucosidase alfa-atga) + Opfolda (miglustat) for the Treatment of Late-Onset Pompe Disease
U.S. FDA Approves Subcutaneous Administration of Takeda’s Entyvio (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis
FDA Approves Bosutinib for Pediatric Patients with Chronic Myelogenous Leukemia
FDA Approves Ryzumvi (phentolamine) Ophthalmic Solution for the Treatment of Pharmacologically-Induced Mydriasis